KAITLIN HAWKINS: Open Payments
NPI 1831711332 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 19 payments from 11 companies in 2025. Trend: 2023 $130 · 2024 $121 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 4 | $64 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Organon LLC | 3 | $47 |
| ABBVIE INC. | 2 | $33 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $21 |
| Biogen, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| Hologic Sales and Service, LLC | 1 | $17 |
| Boston Scientific Corporation | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
Products named: MYFEMBREE, NEXPLANON, Mirena, LILETTA, ZURZUVAE, Veozah, NOVASURE, Bulkamid.
Industry payments across KY — which companies pay providers there.
